 | Up a level |
Batool, M., Berghausen, E. M., Vantler, M., Zierden, M., Baldus, S., Rosenkranz, S. and Ten Freyhaus, H. (2018). Deficiency of the six-transmembrane protein Stamp2 promotes hypoxia-induced pulmonary vascular remodeling and pulmonary hypertension via cross-talk between macrophages and smooth muscle cells. Eur. Heart J., 39. S. 238 - 239. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Berghausen, E. M., Feik, L., Zierden, M., Vantler, M. and Rosenkranz, S. (2019). Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension. Herz, 44 (2). S. 130 - 138. MUNICH: URBAN & VOGEL. ISSN 1615-6692
Ten Freyhaus, H., Batool, M., Berghausen, E. M., Joseph, C., Zierden, M., Vantler, M., Baldus, S. and Rosenkranz, S. (2017). The six-transmembrane protein Stamp2 protects from pulmonary vascular remodeling and pulmonary hypertension in mice. Eur. Heart J., 38. S. 1340 - 1341. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Ten Freyhaus, H., Batool, M., Berghausen, E. M., Zierden, M., Vantler, M., Baldus, S. and Rosenkranz, S. (2016). The six-transmembrane protein Stamp2 protects from experimental pulmonary hypertension. Eur. Heart J., 37. S. 908 - 909. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Ten Freyhaus, H., Berghausen, E. M., Janssen, W., Leuchs, M., Zierden, M., Vantler, M., Baldus, S., Schermuly, R. T., Tallquist, M. D. and Rosenkranz, S. (2014). Critical role of PDGF-induced PI3 kinase and PLCg signaling in human and experimental pulmonary hypertension. Eur. Heart J., 35. S. 198 - 199. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Vantler, M., Alfitian, J., Gerhardt, M., Berghausen, E. M., Zierden, M., Baldus, S., Sandner, P. and Rosenkranz, S. (2018). SGC-stimulation via BAY 41-2272 exerts antiatherogenic effects in LDLR- and ApoE-deficient mice. Eur. Heart J., 39. S. 803 - 804. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Vantler, M., Jesus, J., Leppaenen, O., Chen, X., Gerhardt, M., Berghausen, E., Zierden, M., Baldus, S., Zhao, J. J. and Rosenkranz, S. (2015). PI3Kalpha induced SMC migration and cell cycle progression is crucial for neointima formation following vascular injury. Eur. Heart J., 36. S. 375 - 376. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Zierden, M., Millarg, C., Berghausen, E. M., Baldus, S., Vantler, M. and Rosenkranz, S. (2018). PI3-kinase delta protects against atherosclerosis progression by controlling regulatory T-cell homeostasis and function. Eur. Heart J., 39. S. 254 - 255. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Zierden, M., Millarg, C., Herbers, C., Vantler, M., Berghausen, E., Baldus, S. and Rosenkranz, S. (2014). Hematopoietic PI3-kinase delta-deficiency aggravates lesional macrophage infiltration and atherosclerosis in LDLR-/- mice. Eur. Heart J., 35. S. 614 - 615. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Zierden, M., Millarg, C., Vantler, M., Berghausen, E. M., Baldus, S. and Rosenkranz, S. (2017). Hematopoietic PI3-kinase delta-deficiency aggravates atherosclerosis by impairment of regulatory T cells. Eur. Heart J., 38. S. 1071 - 1072. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645
Zierden, M., Millarg, C., Vantler, M., Berghausen, E. M., Baldus, S. and Rosenkranz, S. (2016). Hematopoietic PI3-kinase delta-deficiency causes B-1 cell depletion, impaired regulatory T-cell function and aggravated atherosclerosis in LDLR-/- mice. Eur. Heart J., 37. S. 1008 - 1010. OXFORD: OXFORD UNIV PRESS. ISSN 1522-9645